Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes

November 19, 2025

Informa 34th Annual Advanced EU Brussels Conference

On November 19, Axinn partner Jimmy Attridge will speak on the "Competition Policy in the New Geopolitical Landscape" panel at Informa's Advanced EU Brussels Conference, being held November 18-19.

Speaking Engagement

Antitrust

November 19, 2025

Kisaco Research Pharma and Biotech Patent Litigation Summit 2025

On November 19, Axinn partner Matthew Murphy will speak on the "Understanding IP Exclusivity Rights Considering the Latest Antitrust Landscape" panel at Kisaco Research's Pharma & Biotech Patent Litigation Summit, being held November 18-19 in Philadelphia.

Speaking Engagement

Intellectual Property

November 18, 2025

GCR Live: Women in Antitrust 2025

On November 18, Axinn partner Lisl Dunlop will speak on "The Next Four Years: Merger Control Following U.S. Leadership Changes" at Global Competition Review's Women in Antitrust conference in Washington, DC.

Speaking Engagement

Antitrust

November 18, 2025

Global Legal Group Global Class Actions Symposium 2025

On November 18, Axinn partner Craig Reiser will chair the "Class Actions in the USA" panel at Global Legal Group's Global Class Actions Symposium, being held November 18-19 in London.

Speaking Engagement

Litigation & Trials

November 12, 2025

ITCTLA Mock Hearing Program 2025

Axinn partners Brian Johnson and Joseph Micallef have been selected to participate as coaches for the International Trade Commission Trial Lawyers Association’s Mock Hearing Program in Washington, DC on November 12. Associates Raymond Braha and Cassie Goodnight have been selected to participate as NEXT Advocates.

Speaking Engagement

Intellectual Property

November 3, 2025

IBA Annual Conference 2025

On November 3, Axinn antitrust practice chair Mike Keeley will speak on the "Competition Law Compliance in the World of Shifting Antitrust Enforcement and High Tech" panel at the International Bar Association's Annual Conference, being held November 2-7 in Toronto.

Speaking Engagement

Antitrust

October 28, 2025

Axinn Partners Ranked in the 2026 Edition of Benchmark Litigation

Axinn partners Matt Becker, Aziz Burgy, Ted Mathias, Denise Plunkett, and Thomas Rohback were selected as “Litigation Stars” for the 2026 Edition of Benchmark Litigation. Partner Craig Reiser was selected as a “Future Star.” Additionally, Axinn is ranked as a “Recommended Firm” in Connecticut and is ranked in Tier Two for intellectual property.

Awards & Recognitions

Litigation & Trials

October 24, 2025

GCR Live: Global Merger Control 2025

On October 24, Axinn partner Bradley Justus will speak on the "Scoping Remedies in Merger Control: Permissive or Restrictive?" panel at Global Competition Review's Global Merger Control Conference, being held October 23-24 in Brussels.

Speaking Engagement

Antitrust

October 24, 2025

Patent Eligibility in the AI Era: Aligning Judicial Precedent With USPTO Guidance

Axinn partners Brian Johnson and Joseph Micallef, along with associate Darpan Singh, co-authored the IAM article, "Patent Eligibility in the AI Era: Aligning Judicial Precedent With USPTO Guidance."

Byline Articles

Intellectual Property

October 23, 2025

Thomson Reuters 24th Annual Law Firm COO & CFO Forum

On October 23, Axinn Chief Operating Officer Ann Westover will speak on the "Invisible Ink: Reputational and Operational Risk Assessment" panel at Thomson Reuters' Annual Law Firm COO & CFO Forum.

Speaking Engagement

October 22, 2025

LegalNEXT 2025

On October 22, Axinn counsel Kenina Lee will speak on the "Algorithms and Antitrust: The Legal Risks of AI-Driven Pricing" panel at Transperfect Legal's LegalNext conference in New York.

Speaking Engagement

Antitrust

October 21, 2025

Axinn Partners Named to Lawdragon's 2026 "500 Leading Dealmakers in America" Guide

Axinn is pleased to announce that Lawdragon has recognized eleven partners in its 2026 “500 Leading Dealmakers in America” guide.

Awards & Recognitions

Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes

Related People

Related Services

Featured Insights

Featured Insights